Search Results - Franzen, Fabian

Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial by Fürstenau, Moritz (Author) , Giza, Adam (Author) , Weiss, Jonathan (Author) , Kleinert, Fanni (Author) , Robrecht, Sandra (Author) , Franzen, Fabian (Author) , Stumpf, Janina (Author) , Langerbeins, Petra (Author) , Al-Sawaf, Othman (Author) , Simon, Florian (Author) , Fink, Anna-Maria (Author) , Schneider, Christof (Author) , Tausch, Eugen (Author) , Schetelig, Johannes (Author) , Dreger, Peter (Author) , Böttcher, Sebastian (Author) , Fischer, Kirsten (Author) , Kreuzer, Karl-Anton (Author) , Ritgen, Matthias (Author) , Schilhabel, Anke (Author) , Brüggemann, Monika (Author) , Stilgenbauer, Stephan (Author) , Eichhorst, Barbara (Author) , Hallek, Michael (Author) , Cramer, Paula (Author) ,

• Verlag, lizenzpflichtig, Volltext